Margareth Jorvid
Direttore/Membro del Consiglio presso ELICERA THERAPEUTICS AB
Provenienza dei contatti di primo grado di Margareth Jorvid
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
26
| Public Company | Biotechnology | 26 |
14
| Public Company | Pharmaceuticals: Major | 14 |
| Public Company | Biotechnology | 9 | |
The Organisation for Professionals in Regulatory Affairs Ltd
 The Organisation for Professionals in Regulatory Affairs Ltd Miscellaneous Commercial ServicesCommercial Services The Organisation for Professionals in Regulatory Affairs Ltd is a professional membership organization that provides training courses, conferences, and networking opportunities for individuals engaged in regulatory affairs for human and veterinary medicines and medical devices worldwide. The non-profit company is based in London, UK. The organization offers resources for improving professional competence and industry standing, including newsletters, medical device resources, and a glossary of regulatory affairs terms.
1
| Non-Profit Organization | Miscellaneous Commercial Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Margareth Jorvid tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| IDOGEN AB (PUBL) | Biotechnology | Director of Finance/CFO Sales & Marketing Chief Executive Officer Chairman Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO | |
| ECTIN RESEARCH AB | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chairman | |
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer Chief Executive Officer Director of Finance/CFO | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
| University of Leiden | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| SELECTIMMUNE PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Maida Vale Capital AB
 Maida Vale Capital AB Investment Banks/BrokersFinance Maida Vale Capital AB is a private company based in Saltsjo-Boo, Sweden. The CEO of the Swedish company is Oliver Aleksov. | Investment Banks/Brokers | Director/Board Member Chairman | |
| Hunterhex AB | Director/Board Member Director/Board Member | ||
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Founder General Counsel | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| DIGNITANA AB | Medical Specialties | Director/Board Member Director/Board Member | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member | |
| ALLENEX AB | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
| Medivir Personal AB | Corporate Officer/Principal Director/Board Member | ||
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal | |
| Glycovisc BioTech AB | Corporate Officer/Principal Director/Board Member | ||
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree | |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Undergraduate Degree | |
| Centre For Advanced Medical Products | Director/Board Member Director/Board Member | ||
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Svezia | 36 |
| Paesi Bassi | 8 |
| Stati Uniti | 4 |
| Regno Unito | 3 |
| Danimarca | 3 |
Settori
| Health Technology | 29 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 211 |
| Corporate Officer/Principal | 122 |
| Chairman | 70 |
| Independent Dir/Board Member | 60 |
| Chief Executive Officer | 59 |
Contatti più connessi
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Eva Agneta Edberg | 45 |
| Dharminder Singh Chahal | 25 |
| Sven Arne Andréasson | 24 |
| Karl Blom | 23 |
| Anders Waas | 21 |
| Sven Rohmann | 20 |
| Magnus Nilsson | 19 |
| Kerstin Valinder-Strinnholm | 18 |
| Lars Martin Lindström | 16 |
| Andrea van Elsas | 16 |
| Bengt Daniel Furberg | 16 |
| Christina Elisabeth Herder | 15 |
| Erik Esveld | 15 |
| Carlos de Sousa | 14 |
- Borsa valori
- Insiders
- Margareth Jorvid
- Connessioni Società
